Happy Birthday, Yvonne Diaz ! You are a wonderful friend and I am so honored to work alongside you supporting #lungcancer advocacy and Team CANCAN’s work on cachexia! Enjoy your special day! Oncogene Cancer Research Cancer Grand Challenges ALK Positive

Excited to share the “oncologist’s perspective” on the role of molecular testing in lung cancer during the #plenary session at #AABIP2025! Grateful to my interventional pulmonary colleagues for the invitation. See you soon, Austin! 🤠 AABIP

💥🚨 Ph I trial of DLL3/CD3 T-cell engager obriktamig in SCLC & NECs (Journal of Clinical Oncology): ascopubs.org/doi/10.1200/JC… ▪️ n=168, 72% ≥2L, 51% prior ICI 🎯 ORR 23% (B2/B3 ≥90 µg/kg: 28%) ▪️ SCLC 21%, epNEC 27%, LCNEC-L 70% ⏱️ DoR 8.5 mo | ⚠️ CRS any grade: 57%, ≥G3: 3% Obriktamig may

Important paper put out by stellar MDA colleagues! Congrats to all co- authors. Lauren Averett Byers, MD Natalie Vokes John Heymach MD Anderson Cancer Center

A #MedEd dream come true 🥹 Honored to co-author the lung cancer chapter in Harrison’s Internal Medicine with mentor/role model/friend, Christine Lovly, MD, PhD, FASCO. From studying Harrison’s first as a med student >13 yrs ago to now contributing, I’m so grateful! #lcsm

Excited for this analysis of #HER2 alterations/overexpression is now out in The Oncologist! 👇 Hem-Onc Fellows Network LungCancerRx 🫁💊 OncoAlert OncoDaily

Out in JTO & JTO CRR research shows that immunohistochemistry (IHC) is a more reliable method to detect MTAP deficiency in non-small cell lung cancer than using CDKN2A gene loss as a surrogate. This is key for accurately selecting patients for targeted therapies! LungCancerRx 🫁💊

Young Lung Cancer Initiative Lung Cancer Research Foundation LUNGevity Foundation Eric K. Singhi, MD LungCancerRx 🫁💊 American Lung Association Oncogene Cancer Research CU Cancer Center MD Anderson Cancer Center A Breath of Hope Lung Cancer Foundation The ROS1ders, Inc. ALK Positive EGFR Resisters RETpositive The White Ribbon Project™ AACR ASCO

🎙️ We learned so much from the insights of Christine Lovly, MD, PhD, FASCO while recording this episode of the LungCancerRx 🫁💊 #podcast. Tune in — I hope patients and providers alike find this conversation helpful and empowering. Aakash Desai, MD, MPH, FASCO Eric K. Singhi, MD Oncology News Central #LCSM #LungCancerRx

Kudos to the team for publishing these results! We learn as much from negative studies as we do from positive ones! Hopefully this will further our understand of Nectin-4 ADCs in NSCLC! LungCancerRx 🫁💊 Tejas Patil

It has been a year since the world lost this sweet soul. A year since she has held her baby boy. A life ended when it really had just begun. Forever 28. Lung Cancer is awful.

🚨 Trial Launch! Excited for my investigator-initiated DISCERN study now LIVE UAB O'Neal Comprehensive Cancer Center! ➡️PD-L1- advanced #NSCLC with ctDNA response to understand dual vs single IO + chemo, a pragmatic trial! IASLC LungCancerRx 🫁💊 Oncology Brothers Clinical Lung Cancer bit.ly/41pf8N2

The (wildest) dream:

Hi friends, it's #LungCancer Wednesday. Here are Top Posts of the Week! 🎉🎉🎉 1/ Stephen V Liu, MD on rebiopsy after progression on targeted therapy for NSCLC: x.com/StephenVLiu/st…

📢Early Career Investigators, if you are building your IASLC #WCLC25 agenda, this workshop on Saturday, Sept 6, 2025, organized by the IASLC #Career #Development Committee is a must-attend for you.... Co-Chairs Jair Bar Ticiana Batista (Leal) Lei Deng, MD (He/Him) Sabita Jiwnani has designed a

If you told me a few years ago I’d be invited to speak at IASLC #WCLC25, not just on research, but on how social media fuels patient education & advocacy, I’d have said you were CRAZY. Lean into what you love. Even if it’s not the norm. Especially when it helps patients 🤍

We get to learn amazing rad onc wisdom from Nitin at our Tumor board each and every week- but here on X this might be a unique chance so make sure to take advantage of! Listen to his excellent patient-centered talk introducing novel concepts from digital tools to neoadjuvant

Thank you to the Oncology Brothers PER for the opportunity to highlight how I manage AEs with the recent advancements in #SCLC #tarlatamab #lurbinectedin. A high yield discussion! Worth a listen! 🎧 SmallCellSMASHERS Hossein Borghaei, DO

🚨 Plans for the long weekend? 🤔 Get ready for #WCLC25! 🌍 Amazing science awaits... ➡️Check out my top picks! 💥 What are some others you are excited about? LungCancerRx 🫁💊 Oncology Brothers OncoAlert IASLC Jarushka Naidoo Umberto Malapelle Noemi Reguart Isabelle Opitz